找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Difficult Acute Cholecystitis; Treatment and Techni Isidoro Di Carlo Book 2021 Springer Nature Switzerland AG 2021 Acute cholecystitis.chol

[復(fù)制鏈接]
樓主: palliative
11#
發(fā)表于 2025-3-23 13:16:46 | 只看該作者
12#
發(fā)表于 2025-3-23 17:50:55 | 只看該作者
Pathophysiology and Diagnosis of Acute Acalculous Cholecystitis, should be screened in all critically ill or injured patients with sepsis, especially in cases where the cause of sepsis is not clear, in case of hypoperfusion, onset of jaundice, and/or postoperative setting.
13#
發(fā)表于 2025-3-23 20:36:13 | 只看該作者
Tokyo Guidelines and Their Limits,n numerous research studies of acute cholecystitis, there is still room for discussion about the flowchart for management. Here, we describe the outlines of TG18 and room for its improvement in the future.
14#
發(fā)表于 2025-3-24 01:56:57 | 只看該作者
Difficult Laparoscopic Cholecystectomy: Timing for Conversion,hlight the importance of conversion as wise approach in the difficult cholecystectomy case where the risks of continuing with the laparoscopic cholecystectomy clearly outweigh the morbidity that comes with conversion to open.
15#
發(fā)表于 2025-3-24 03:52:00 | 只看該作者
When Is It Safe to Continue Laparoscopically?,e surgical exposure, (5) consult for a second opinion, and (6) the adoption of alternative laparoscopic procedures (subtotal cholecystectomy, cholecystostomy) or conversion to laparotomy. A calm, reflective and shared responsibility attitude is essential for surgical decision-making for the development of a safety culture during cholecystectomy.
16#
發(fā)表于 2025-3-24 08:36:16 | 只看該作者
17#
發(fā)表于 2025-3-24 11:51:16 | 只看該作者
18#
發(fā)表于 2025-3-24 18:45:11 | 只看該作者
19#
發(fā)表于 2025-3-24 19:38:03 | 只看該作者
20#
發(fā)表于 2025-3-25 02:49:52 | 只看該作者
Verfahrensbeschreibung Tiefziehen,elderly population. The aim of this chapter is to combine and briefly summarize the WSES guidelines on ACC and to provide a quick and easy-to-use tool for physicians treating this challenging disease.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 19:36
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
玉环县| 汪清县| 巫山县| 凤台县| 贵阳市| 临潭县| 方山县| 新邵县| 弥勒县| 平原县| 神池县| 哈密市| 衡东县| 多伦县| 玉门市| 滕州市| 五台县| 高唐县| 红原县| 新民市| 新龙县| 绥芬河市| 宁南县| 监利县| 金平| 黔西县| 本溪市| 乐清市| 扬州市| 昭觉县| 偏关县| 和顺县| 阆中市| 贵德县| 保定市| 上饶市| 城口县| 紫阳县| 高台县| 肃北| 太白县|